facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2022
vol. 109
 
Share:
Share:
abstract:
Case report

PRIDE syndrome with lumbosacral hypertrichosis

Saima Naaz
1
,
Hania Qamar Khan
1
,
Syed Suhail Amin
1
,
Shriya Kaushik
1
,
Shagufta Qadri
2

  1. Department of Dermatology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India
  2. Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India
Dermatol Rev/Przegl Dermatol 2022, 109, 321-326
Online publish date: 2023/01/16
View full text Get citation
 
PlumX metrics:
Introduction
The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, Dryness due to EGFR inhibition) syndrome is a cutaneous adverse effect of EGFR inhibitors.

Case Report
We describe an 80-year-old man, who presented with itchy papules over the suprapubic region and hair growth over the lower back for 1 month. He was diagnosed with squamous cell carcinoma of the lung, and was treated with oral gefitinib 250 mg daily for 4 months. Cutaneous examination revealed generalized xerosis, discrete papules and pustules with overlying yellow crusts over the suprapubic region, and paronychia with dystrophic changes over the right first and third toe nail. Localised hypertrichosis was seen over the back in midline lumbosacral region.

Conclusions
Hair overgrowth such as trichomegaly and hypertrichosis have been described in the PRIDE syndrome. We describe an atypical presentation of the syndrome with lumbosacral hypertrichosis.

keywords:

hypertrichosis, epidermal growth factor receptor inhibitors, adverse drug reaction, geftinib



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.